News

November 21, 2011 – Royal Philips Electronics introduced Philips HeartStart FR3 automated external defibrillator (AED) in the United States for professional responders who treat victims of sudden...

November 16, 2011 – Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to standard antiplatelet therapy significantly reduced the composite...

November 15, 2011 – A clinical trial that compared the use of drug-eluting balloons (DEB) and bare metal stents (BMS) to both bare metal stents alone and drug-eluting...

October 26, 2011 — Medtronic Inc. announced the start of SYMPLICITY HTN-3, the company’s United States clinical trial of the Symplicity Renal Denervation System for treatment-resistant...

September 13, 2011 – A new study finds that infections following cardiac device implantations or replacement result in extremely high costs, both financially and in terms of patient mortality,...

September 12, 2011 — Cardiovascular market research firm Zacks Equity Research released a new report discussing high growth areas in medical devices, including Medtronic Inc., Boston Scientific...

August 31, 2011 — A recent study revealed more than 1,000 cardiac arrest deaths over 15 years are connected to the failure of automated external defibrillators (AEDs); battery failure accounted...

August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent System for the treatment of renal artery stenosis (narrowing of the main arteries...

August 2, 2011 – The U.S. Food and Drug Administration recently cleared Abbott Vascular’s RX Herculink Elite Renal Stent System. The balloon-expandable, cobalt chromium, laser-cut stent is used to...

July 14, 2011 — The U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the U.S. clinical trial of renal denervation with the Symplicity catheter...

June 14, 2011 – New performance measures for adults with coronary artery disease (CAD) and hypertension were released today by the American College of Cardiology Foundation (ACCF), the American Heart...
May 19, 2011 - Results from a study validating Cheetah Medical's noninvasive NICOM system specifically for use in patients with pulmonary hypertension were presented Wednesday, May 18th, at the 2011...
May 6, 2011 – The U.S. Food and Drug Administration has released its list of pre-market approval (PMA) decisions for new or enhanced medical devices from March 2011.
May 6, 2011 – A substance secreted by the heart that is associated with congestive heart failure and renal failure is not predictive of reduction in systolic blood pressure in patients treated with...
A new version of the Lifepak 15 monitor/defibrillator is designed to help hospital, as well as pre-hospital, teams provide more effective patient care. The 15, when used together with CODE-STAT data...

April 21, 2011 – A new angiotensin II receptor blocker (ARB) has been approved by the U.S. Food and Drug Administration (FDA) to treat hypertension, or high blood pressure. Edarbi (azilsartan...

March 30, 2011 – Interventional radiologists have completed the first human randomized controlled trial of therapeutic renal denervation, or RDN. RDN is a procedure that uses a catheter-based...

March 18, 2011 – Researchers have found a link between high blood pressure and a greater drop in average walking speeds in older adults, according to results from a new study. The drop seems to...

March 14, 2011 – A software system that manages patient itineraries has expanded into the cardiology and transport departments. Allocade’s On-Cue Expert Software System and enhancements for the On...

March 11, 2011 – Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another possible use – helping children and young adults with congenital heart disease to...